Absci Corporation Common Stock (ABSI)
Absci Corporation is a biotechnology company specializing in artificial intelligence-driven drug discovery and development. It leverages its proprietary platform to streamline the creation of biologics and identify new therapeutic candidates efficiently, aiming to accelerate the journey from discovery to clinical trials.
Company News
Absci partnered with Oracle Cloud Infrastructure and AMD to accelerate AI-driven drug discovery, leveraging high-performance computing infrastructure for molecular simulations and antibody design.
Absci Corporation announced participation in upcoming healthcare investor conferences and highlighted its AI-driven drug discovery platform, focusing on innovative therapeutics like ABS-101 for inflammatory bowel disease and ABS-201 for hair regrowth.
The article discusses four biotech companies leveraging AI and machine learning technology to improve drug discovery and development processes. These companies are Absci, Firefly Neuroscience, Korro Bio, and NeuroSense Therapeutics.
Cathie Wood's Ark Invest has been buying shares of Tempus AI, Blade Air Mobility, and Absci despite a rough year for growth investors. Tempus AI and Absci are using AI for healthcare solutions, while Blade Air Mobility operates a helicopter transport service.
The focus is likely to be on progress on its pipeline candidates when generative AI drug creation company Absci (ABSI) reports first-quarter results.